Competing interests
Hoffman‐LaRoche
DAA is a former employee of Endpoint Outcomes and a current employee of BioMarin Pharmaceutical, Inc. RFG received research funding from Agios Pharmaceuticals Inc., Novartis, and Sobi and consultancy from Agios Pharmaceuticals Inc., and Sanofi. RJK reports consultancy from Agios Pharmaceuticals Inc., Amgen, Biogen Canada Limited, Hoffman‐LaRoche Ltd, Novo Nordisk Canada Inc, Octapharma AG, Sanofi Genzyme, and Takeda Canada Inc. SS reports consultancy for Merck Healthcare KGaA and education grants from GlaxoSmithKline and The European Haematology Association. JL, FT, and ANB are employees and shareholders of Agios Pharmaceuticals Inc. EZ is a former employee and shareholder of Agios Pharmaceuticals Inc. AJ and BF are employees of Endpoint Outcomes (now Lumanity).